½ÃÀ庸°í¼­
»óǰÄÚµå
1447613

³»½Ã°æ°Ë»ç¿ë À¯Ã¼ °ü¸® ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº° - ¼¼°è ¿¹Ãø(2024-2032³â)

Endoscopy Fluid Management Market - By Product Type, By Application, By End-use - Global Forecast, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 170 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ³»½Ã°æ°Ë»ç¿ë À¯Ã¼ °ü¸® ½ÃÀå ±Ô¸ð´Â ÷´Ü ³»½Ã°æ ½Ã½ºÅÛÀÇ µµÀÔ¿¡ ÀÇÇØ ÃËÁøµÇ¸ç 2024-2032³â CAGR 7.2%¸¦ ±â·ÏÇÕ´Ï´Ù.

ÃÖ±Ù ÀÇ·á ½Ã¼ú Áß ½Ã°¢È­ ¹× Áø´Ü ´É·ÂÀ» °­È­ÇÏ´Â ÃÖ÷´Ü ½Ã½ºÅÛÀÌ ³Î¸® ¼±È£µÇ¸é¼­ È¿À²ÀûÀÎ À¯Ã¼ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ÀÇ·á ±â¼ú ±â¾÷ ¿Ã¸²Çª½º´Â 2023³â 12¿ù ¼ÒÈ­±â(GI) Àü¹®ÀǸ¦ À§ÇØ °³¹ßÇÑ Ãֽг»½Ã°æ ½Ã½ºÅÛ 'EVIS X1'À» ¹ßÇ¥Çß½À´Ï´Ù.

ȯÀÚ °á°ú¿Í ½Ã¼ú È¿À²¼º Çâ»ó¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº À¯Ã¼ °ü·ù, ÈíÀÔ ¹× Æó±â¹° 󸮸¦ ÃÖÀûÈ­ÇÏ´Â Çõ½ÅÀûÀÎ À¯Ã¼ °ü¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ³»½Ã°æ °Ë»ç°¡ Áß¿äÇÑ Áø´Ü ¹× Ä¡·á Åø·Î °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó °í±Þ À¯Ã¼ °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀåÀÇ ¼ºÀå ±Ëµµ¸¦ ´õ¿í °¡¼ÓÈ­ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿ëµµº°·Î´Â º¹°­°æ °Ë»ç ºÐ¾ß°¡ 2024-2032³â 7.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º¹°­°æ ¼ö¼úÀÌ ÃÖ¼Ò Ä§½À ¼ö¼ú·Î Á¡Á¡ ´õ ´ëÁßÈ­µÊ¿¡ µû¶ó È¿À²ÀûÀÎ ¼ö¾× °ü¸®´Â °¡½Ã¼ºÀ» À¯ÁöÇϰí ȯÀÚ °á°ú¸¦ ÃÖÀûÈ­ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÷´Ü ¼ö¾× °ü¸® ½Ã½ºÅÛÀº ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¸íÈ®ÇÑ ¼ö¼ú ºÎÀ§¸¦ È®º¸Çϱâ À§ÇØ °ü°³¿Í ÈíÀÔÀ» Á¤¹ÐÇÏ°Ô Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ À¯Ã¼ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÇÔ²² ´Ù¾çÇÑ ¼ö¼ú Àü¹® ºÐ¾ß¿¡¼­ º¹°­°æ ±â¼úÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ºÎ¹®ÀÇ ³»½Ã°æ°Ë»ç¿ë À¯Ã¼ °ü¸® »ê¾÷ ¸ÅÃâÀº 2024-2032³â 6.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿Ü·¡ ¼ö¼úÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸íÈ®ÇÑ °¡½Ã¼º°ú ÃÖÀûÀÇ È¯ÀÚ °á°ú¸¦ º¸ÀåÇϱâ À§ÇØ È¿À²ÀûÀÎ À¯Ã¼ °ü¸®°¡ ¸Å¿ì Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)´Â ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 Á¤È®ÇÑ °ü·ù ¹× ÈíÀÔ Á¦¾î¸¦ Á¦°øÇÏ°í ½Ã¼úÀÇ È¿À²¼ºÀ» ³ôÀ̱â À§ÇØ Ã·´Ü ¼ö¾× °ü¸® ½Ã½ºÅÛÀ» ¿ä±¸Çϰí ÀÖÀ¸¸ç, ASC°¡ ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µ¥ ÀÖÀ¸¸ç, Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ´Â ¸¸Å­, ÀÌ·¯ÇÑ ¿ä±¸¿¡ ¸Â´Â Çõ½ÅÀûÀÎ ¼ö¾× °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÌ ºÐ¾ßÀÇ È®ÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

À¯·´ ³»½Ã°æ°Ë»ç¿ë À¯Ã¼ °ü¸® ½ÃÀåÀº 2024-2032³â ¿¬Æò±Õ 7%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÇ·á ±â¼úÀÇ ¹ßÀü°ú ȯÀÚ °á°ú °³¼±¿¡ ÃÊÁ¡À» ¸ÂÃá À¯·´ÀÇ ÀÇ·á ½Ã¼³Àº ³»½Ã°æ ½Ã¼ú Áß È¿À²ÀûÀÎ À¯Ã¼ °ü¸®¸¦ ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù. ÷´Ü À¯Ã¼ °ü¸® ½Ã½ºÅÛÀº °ü°³¿Í ÈíÀÔÀ» Á¤¹ÐÇÏ°Ô Á¦¾îÇÏ¿© ¼±¸íÇÑ ½Ã¾ß¸¦ È®º¸Çϰí ȯÀÚÀÇ ºÒÆíÇÔÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù. À¯·´ÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ ¹ßÀüÇϰí ÀÖÀ¸¸ç, ƯÁ¤ ¿ä±¸»çÇ׿¡ ¸Â´Â Çõ½ÅÀûÀÎ À¯Ã¼ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ªÀÇ »ê¾÷ ¼ºÀåµµ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • Àúħ½À¼ö¼ú¿¡ ´ëÇÑ ¼ö¿äÀÇ Áõ°¡
      • À¯Ã¼ °ü¸® ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸
      • ³»½Ã°æ ½Ã¼úÀ» ÇÊ¿ä·Î ÇÏ´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ³»½Ã°æ ½Ã¼úÀÇ °íºñ¿ë
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®
  • »óȯ ½Ã³ª¸®¿À
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • °¸ ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç° À¯Çüº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ³»½Ã°æ°Ë»ç¿ë À¯Ã¼ °ü¸® ½Ã½ºÅÛ
  • ³»½Ã°æ°Ë»ç¿ë À¯Ã¼ °ü¸® ¾×¼¼¼­¸®

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • °üÀý°æ °Ë»ç
  • º¹°­°æ °Ë»ç
  • ÀÚ±Ã°æ °Ë»ç
  • ±âŸ ¿ëµµ

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø
  • Áø·á¼Ò
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • Arthrex, Inc.
  • B. Braun SE
  • CONMED Corporation
  • Hologic Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew
  • STERIS plc
  • STRYKER Corporation
KSA 24.03.26

Global Endoscopy Fluid Management Market size will witness 7.2% CAGR between 2024 and 2032 driven by the introduction of advanced endoscopy systems. Of late, several cutting-edge systems are widely preferred as they offer enhanced visualization and diagnostic capabilities during medical procedures, further necessitating efficient fluid management solutions. For instance, in December 2023, Olympus, a medical technology company, unveiled its latest advancement, the EVIS X1 endoscopy system, tailored for gastrointestinal (GI) practitioners.

The strong focus on improving patient outcomes and procedural efficiency is driving healthcare providers to seek innovative fluid management technologies to optimize fluid irrigation, suction, and waste disposal. With endoscopy continuing to evolve as a crucial diagnostic and therapeutic tool, the demand for sophisticated fluid management systems may rise, further shaping the market growth trajectory.

The overall industry is classified into product type, application, end-use and region.

Based on application, the market share from the laparoscopy segment will undergo significant development while depicting a 7.6% CAGR from 2024 to 2032. As laparoscopy becomes increasingly prevalent in minimally invasive surgeries, efficient fluid management is essential for maintaining visibility and optimizing patient outcomes. Advanced fluid management systems offer precise regulation of irrigation and suction for ensuring a clear operative field while minimizing patient discomfort. The growing adoption of laparoscopic techniques across various surgical specialties along with the higher demand for innovative fluid management solutions will add to the segment growth.

Endoscopy fluid management industry revenue from the ambulatory surgical centers segment will register a 6.9% CAGR from 2024 to 2032. With the rise in outpatient procedures, efficient fluid management has become crucial for ensuring clear visualization and optimal patient outcomes. Ambulatory surgical centers (ASCs) seek advanced fluid management systems to offer precise irrigation and suction control as well as enhancing procedural efficiency while minimizing patient discomfort. As ASCs continue to play a significant role in delivering high-quality care, the demand for innovative fluid management solutions tailored to their needs will propel the segment expansion.

Europe endoscopy fluid management market will showcase a 7% CAGR from 2024 to 2032. With a focus on advancing healthcare technology and improving patient outcomes, European medical facilities are prioritizing efficient fluid management during endoscopic procedures. Advanced fluid management systems offer precise control over irrigation and suction for ensuring clear visualization and minimized patient discomfort. The evolving European healthcare infrastructure and the growing need for innovative fluid management solutions tailored to the specific requirements will also drive the regional industry growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for minimally invasive procedures
      • 3.2.1.2 Technological advancements in fluid management systems
      • 3.2.1.3 Increasing prevalence of chronic diseases requiring endoscopic procedures
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of endoscopic procedures
  • 3.3 Growth potential analysis
  • 3.4 Porter's analysis
    • 3.4.1 Supplier power
    • 3.4.2 Buyer power
    • 3.4.3 Threat of new entrants
    • 3.4.4 Threat of substitutes
    • 3.4.5 Industry rivalry
  • 3.5 PESTEL analysis
  • 3.6 Reimbursement scenario
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Endoscopy fluid management systems
  • 5.3 Endoscopy fluid management accessories

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Arthroscopy
  • 6.3 Laparoscopy
  • 6.4 Hysteroscopy
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Ambulatory surgical centers
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Arthrex, Inc.
  • 9.2 B. Braun SE
  • 9.3 CONMED Corporation
  • 9.4 Hologic Inc.
  • 9.5 Johnson & Johnson
  • 9.6 KARL STORZ SE & Co. KG
  • 9.7 Medtronic plc
  • 9.8 Olympus Corporation
  • 9.9 Richard Wolf GmbH
  • 9.10 Smith & Nephew
  • 9.11 STERIS plc
  • 9.12 STRYKER Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦